Opioids for the management of chronic non-malignant pain
There has been a dramatic increase in the use of opioid analgesics for the management of chronic non-cancer pain. With the increase in prescribed opioids, there has also been an increase in emergency department visits, prescription drug substance abuse admissions, overdoses and deaths.
In Arkansas, 2.49 million opioid prescriptions were filled in 2020 a reduction from the 2.69 million opioid prescriptions filled in 2019. Although the number of opioids prescribed in Arkansas has decreased, Arkansas remains one of the leading states in the nation for opioid prescribing. According to the Centers for Disease Control and Prevention in 2019, Arkansas’ rate of 80.9 prescriptions per 100 people is still well above the national average of 46.7.
Research shows that if dosing guidelines are not followed, there is an increased risk of side effects and unintentional overdose. Most physicians who prescribe opioids for chronic pain have not received formal training in chronic pain management.
Strategies for success
Know the facts about opioids.
- Use the lowest effective dose. Use caution and reassess before increasing dosage to ≥50 morphine milligram equivalent (MME) per day. Avoid increasing dosage to ≥90 MME/day.
- Dose escalation has not been proven to be effective for chronic non-malignant pain.
- The risk of overdose or death increases with dosage.
- Opioid dependence can develop in as little as days or weeks with daily use.
- Patients developing opioid dependence may have difficulty tapering dosages.
- Other risks associated with opioid use include tolerance, increased pain sensitivity, respiratory depression, unintentional overdose and chronic constipation.
- The risk of respiratory depression increases when opioids are combined with benzodiazepines and other non-opioid medications with sedative side effects.
- Polypharmacy occurs frequently with elderly and critically ill populations causing an increased risk for adverse drug events.
- Approximately one half of deaths resulting from prescription pain medication involve the use of at least one other drug.
Management of patients on opioids
- Check the Prescription Drug Monitoring Program (PDMP) every time when prescribing a Schedule II or Schedule III opioid and the first time a benzodiazepine is prescribed.
- Document in the patient record that the PDMP was checked.
- Consider multimodal therapies such as superficial cold/heat therapy, spinal manipulation, physical therapy, psychotherapy, acupuncture, massage, etc.
- Get informed consent with a discussion of the benefits and risks of opioid management in patient record.
- Get a signed pain contract and baseline urine drug screen.
- Evaluate the patient at least once every six months by a physician licensed by the Arkansas State Medical Board.
- Conduct random urine drug screens and pill counts.
- Consider co-prescribing Naloxone when clinically appropriate.
- Periodically review the scheduled drug treatment with the patient and any new information about the etiology of the pain and appropriateness of continuing medications.
- Keep accurate records of medical history, physical examination, evaluations and consultations, treatment plan objective, informed consents, agreements, and medications prescribed.
- Advise where and how to safely dispose of all unused, unwanted or expired medications.
Improve office systems
- Using an Electronic Medical Record (EMR) for prescribing may assist in the management of potential drug interactions.
- Patients receiving chronic opioid therapy benefit from a medical home in which the primary care provider directs care and coordinates consults with other care providers as needed.
What you should teach your patients about opioids?
- Inform your doctor about all medications currently taking and do not begin any medications without first consulting your doctor.
- Do not take more than the prescribed amount.
- Report side effects to your doctor.
- Do not share opioid/pain medication with others.
- Keep opioid/pain medications locked away to keep others safe.
- Avoid driving and activities that require alertness since drowsiness and dizziness can occur.
- Avoid drinking alcohol while taking pain medication.
- Do not throw away or flush unused opioid/pain medications. Take unused medication to drop-off locations sponsored by local police departments.
- Check to see if your local pharmacy has a drop-off box.
- Participate in Drug Take Back Day and encourage your friends and family to participate as well.
Opioid Prescribing for Chronic Nonmalignant Pain Physician resources
- Check PDMP every time prescribing a Schedule II or Schedule III opioid and the first time a benzodiazepine is prescribed. arkansas.pmpaware.net/login
- Get informed consent with discussion of benefits and risks of opioid therapy noted in patient record. www.ihs.gov/sites/painmanagement/themes/responsive2017/display_objects/documents/SampleConsentControlSub.pdf
- Get signed pain contract and baseline urine drug screen.
- Use the lowest effective dose. Use caution and reassess before increasing dosage to ≥50 morphine milligram equivalent (MME) per day. Avoid increasing dosage to ≥90 MME/day. www.agencymeddirectors.wa.gov/Calculator/DoseCalculator.htm
- Review treatment plan with assessment of appropriateness. www.agencymeddirectors.wa.gov/AssessmentTools.asp
- Advise where and how to safely dispose of all unused, unwanted or expired medications www.artakeback.org/
- Arkansas Medical Society https://www.arkmed.org/resources/prescription-drug-education/
- Arkansas Emergency Department Opioid Prescribing Guidelines
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Deborah Dowell, MD, MPH1; Tamara M. Haegerich, PhD1; Roger Chou, MD1
Author Affiliations Article Information
JAMA. 2016;315(15):1624-1645. doi:10.1001/jama.2016.1464
CDC Warns of Misapplication of Its Opioid Guideline: Family Physician Expert Offers Insight on Misinterpretations
Crawford, Chris, 2019
Reducing the Risks of Relief — The CDC Opioid-Prescribing Guideline
Thomas R. Frieden, M.D., M.P.H., Debra Houry, M.D., M.P.H. April 21, 2016
N Engl J Med 2016; 374:1501-1504 DOI: 10.1056/NEJMp1515917